Background Strategies to reduce the burden of cardiovascular disease (CVD) in the UK have emphasized improved management of high-risk individuals rather than population-based approaches.
Introduction
Elevated blood pressure (BP) is responsible for approximately half of the worldwide burden of cardiovascular disease (CVD). 1 Estimates suggest that eliminating poor BP control would prevent 62 000 deaths from coronary heart disease (CHD) and stroke each year in the UK alone. 2 Moreover, improvements in BP control may reduce health inequalities as mortality from CVD has been shown to be three times higher in the most deprived areas of the UK in comparison to affluent areas. 3 General Practitioner contract. More recently, the government introduced NHS Health Checks, a cardiovascular risk assessment programme, which aims to identify and manage adults at high risk of cardiovascular disease in England. 8 Detailed data on the prevalence of hypertension come from the Health Survey for England (HSE), which focused on cardiovascular disease in 1994, 1998, 2003 and 2006 . These nationally representative surveys suggest that mean BP values in the population have been falling since 1994, and that there have been significant increases in rates of treatment and control among those with hypertension. 9 While data from the HSE are informative, they have limitations including small numbers of patients with CVD, limited data on ethnicity and possible bias arising from undertaking comparisons of cross-sectional data. Previous studies have used data from primary care to examine inequalities in BP measurement and control by deprivation group after the introduction of the Quality and Outcomes Framework (QOF). 10 However, there is currently little information on longer term trends in BP measurement and control and whether known inequalities among age, gender and ethnic groups have persisted.
This study examines trends in BP monitoring and control in persons with and without CVD in southwest London between 1998 and 2007. It also examines inequalities in BP measurement and control among age, gender, ethnic and socio-economic status (SES) groups over this period.
Methods

Study setting and data collection
The study was conducted in Wandsworth, southwest London, which has a younger, more deprived and more culturally diverse population than is typical for England. 11, 12 Twenty-nine of the 34 general practices in the study area participated in the study. Data were extracted directly from individual practice computers using an algorithm applied to each practice to gain all of the relevant data on each patient, including past medical history. We extracted the last BP measurement in each year between 1998 and 2007 from patients aged 45 years, who were registered with practices on the 31 December 2007.
Our main outcome measures were recording of BP measurement and raised BP. We defined BP as being 'raised' if it was higher than 140/90 mm Hg, as in guidance from the National Institute for Health and Clinical Excellence. 13 Our predictor variables were age, gender, ethnicity, SES and number of comorbid cardiovascular conditions. We categorized age into four groups: 45 -54, 55-64, 65 -74 and 75þ years. We categorized ethnicity into four groups (white, black, south Asian and unknown/missing) due to small numbers in individual ethnic subgroups. We assigned each patient to an SES tertile based on their general practice postcode using the Index of Multiple Deprivation (IMD) 2007 (10) . The IMD is the most common way to measure arealevel SES in the UK and is composed of several dimensions, such as income, living environment and unemployment. We identified CVD conditions (stroke, diabetes, heart failure, hypertension, CHD, atrial fibrillation or renal failure) in each year using Read and OXMIS codes. Read codes are the clinical classification system used in primary care in the UK; OXMIS codes were used in the past by some general practices but have now been replaced by Read codes. We grouped patients by the number of comorbid CVD conditions (1, 2, 3þ) in each year.
Data analysis
We calculated the percentage of patients having their BP measured and with raised BP annually by age, gender, ethnic and SES groups. Odds ratios (adjusted for age, sex, IMD of practice and ethnicity) were calculated, with confidence intervals using the Mantel-Haenszel technique. Logistic regression models were used to examine associations among age, sex, ethnicity, deprivation and number of CVD conditions and the measurement and control of BP in 1998 and 2007. We used robust standard errors to take account of clustering of patients within general practices. This takes into account that we would expect patients at the same practice to have more similar outcomes than patients from other practices. We fitted an interaction term for year and CVD status to determine whether trends in BP measurement and control differed between patients with and without CVD. Statistical analyses were performed using Stata 10.0 (Stata Corporation, TX, USA). Table 1 shows the breakdown of the population in this study. In 2007, there were 36 407 patients without CVD and 19 486 with CVD aged 45 years and over in Wandsworth. As expected, the without CVD group was younger than those with CVD with a mean age of 56.0 years in 2007, compared with 66.6 years for the CVD group. There was a much higher percentage with unknown/missing ethnicity among the non-CVD group than among those with CVD (39.9 and 12.4%, respectively), which reflects the high level of ethnicity coding among those with a long-term condition in Wandsworth, as noted elsewhere. significantly less likely to have raised BP in both years than their white counterparts, although this difference has narrowed from 13.6 to 9.3%. Patients with multiple CVD conditions were significantly less likely to have raised BP than those with a single CVD condition in 2007. The percentage of patients without CVD with raised BP has declined from 31.0 to 25.3% (Fig. 1b, Table 3 
Results
Discussion Main findings of this study
This population-based study shows that there have been large improvements in both the measurement and control of BP over the past decade among persons with CVD. Much of this improvement occurred before the implementation of the QOF in 2004. Comparatively modest improvements were found among individuals without CVD, although our data indicate that (QOF) targets for BP monitoring in this group (80% having their BP measured every 5 years) are being met. Inequalities in BP control decreased among age, ethnic and SES groups over the study period. But some inequalities were still apparent. For example, black patients without CVD remained more likely to have their BP raised than white patients. Also south Asian patients with CVD were less likely to have raised BP than white patients. Differences between men and women without CVD appeared to increase over the study period, with men being less likely to be measured and more likely to have raised BP than women in 2007. Among those with CVD, men were less likely to be measured but were not more likely to have raised BP. This study also found that patients with multiple CVD conditions (1, least deprived; IMD 3, most deprived).
*Significant difference at P 0.05.
were both more likely to have their BP measured and controlled than those with a single CVD condition. This suggests that recent quality improvement initiatives in England may have improved risk factor control more in high-risk patients.
What is already known on this topic?
The relative benefits of population-based strategies, in comparison with high-risk strategies, on cardiovascular health and associated mortality are well established. 15, 16 For example, previous work suggests that equivalent reductions in diastolic BP confer a 10-fold greater decrease in coronary heart disease (CHD) mortality among the general population relative to patients with existing CHD. 17 A comparison of primary and secondary prevention strategies recommended in the National Service Framework for CHD also concluded that over 70 000 CHD per year more cardiovascular events would be prevented by meeting public health and primary prevention targets, compared with 4 170 events prevented by focusing on those with established disease. 18 Our study builds on previous research that has identified important inequalities in BP control between population groups in the UK. Our finding that black patients were more likely to have raised BP than white patients partly fits in with data from the HSE 2004, which found that black women were more likely to have high BP than the general population, and that black Caribbean men had higher mean systolic BP than the general population. 19 The increasing differences between men and women are consistent with the latest data from the HSE, which cites a particularly large improvement in treatment and control of BP among women which was not mirrored in men. 20 Finally, our finding that patients with multiple conditions are more likely to have their BP both measured and controlled is consistent with previous UK and US evidence on the relationship between number of medical conditions and quality of care generally, 21 among patients with hypertension 22 and those with diabetes. 23 This finding may reflect greater contact with primary care among these patients and the impact of the QOF, a pay for performance programme that incentivises improved management of all of the conditions examined in our study.
What this study adds
Our findings indicate that the current emphasis on secondary prevention within UK health policy has led to a more rapid reduction in BP levels among patients with CVD than in the general population. While reductions in BP at the population level are undoubtedly more difficult to achieve, the very modest reductions seen in our study over the past decade indicate that important health gains may be being missed. Our study therefore further highlights the importance of increasing investment in primary prevention initiatives known to reduce BP. These initiatives include efforts to halt and then reverse the obesity epidemic and increase physical activity levels. 24 Despite recent positive trends suggesting increased levels of physical activity in England, improvements have been slow and in 2008 only 39% of adult men and 29% of adult women met the Chief Medical Officer's recommendations for physical activity. 25 Finally, while the UK is considered as a world leader in its efforts to reduce population salt intake, it is of concern that the Food Standards Agency's target for reducing population salt intake to 6 g has now been delayed until 2012, as population-based salt reduction has the potential to deliver BP and mortality reductions to large numbers of people, 26 both with and without hypertension. 27 Our findings finally highlight the importance of ongoing assessment of the impact of population and high-risk strategies on inequalities in BP control.
Limitations of this study
Data were collected on all adult patients registered with 29 of 34 practices in the study area providing a comprehensive picture of BP measurement and control in this urban, ethnically diverse area. However, because we were only able to extract historical data on patients registered in 2007, we lacked information on patients who moved from the area or died during the study period and our sample may be biased towards healthier surviving patients. Further, this meant that the sample size was considerably smaller at the beginning of the study and we may not have had adequate power to detect clinically meaningful differences in BP management. Whilst we had high levels of ethnicity recording among patients with CVD conditions (88%), this was considerably lower among patients without CVD (60%). Our findings relating to ethnic group differences in BP control among patients without CVD should therefore be treated with some caution. We assigned an area-based deprivation score to patients using their general practice postcode. While it would be preferable to employ patient level measures of socio-economic circumstances, such as income or occupational status, these are not routinely recorded in UK general practice. Factors other than the measurement and control of BP would also have been of interest. For example, we do not know whether some of the differences observed in our study are due to prescribing patterns of local doctors, differing adherence to medications or other lifestyle interventions. It would have been informative to examine trends in other risk factors for CVD, such as cholesterol and BMI. However, these remain poorly recorded in general practice information systems at present, i.e. 70% of all patients did not have BMI recorded in 2007. We employed a cut point of 140/90 mm Hg for 'raised' BP based on NICE 13 and other guidance for the diagnosis and management of hypertension. 28 This may not reflect the optimal treatment target for individual conditions. The proportion of patients overall with a valid BP reading in 1998 was 19.4% (4621 patients) while by 2007 this had risen to 55.8% (31 200 patients). Part of the improvement in BP control seen in the CVD group may be due to improved ascertainment of cases with borderline hypertension because of this increased measurement of BP over the study period.
Conclusion
BP control has improved more markedly among those with CVD, compared with those without CVD, in the UK over the past decade. This finding highlights a need to re-evaluate the focus on secondary prevention in the current UK health policy. Inequalities in BP control decreased among age, ethnic and SES groups over the study period. However, differences in BP control between black and white patients have persisted and have increased between men and women.
